a Epicentre , Paris , France.
b Médecins sans Frontières , Geneva , Switzerland.
Glob Public Health. 2019 Aug;14(8):1112-1124. doi: 10.1080/17441692.2018.1561921. Epub 2019 Jan 11.
Increasing numbers of people living with HIV (PLHIV) in sub-Saharan Africa are experiencing failure of first-line antiretroviral therapy and transitioning onto second-line regimens. However, there is a dearth of research on their treatment experiences. We conducted in-depth interviews with 43 PLHIV on second- or third-line antiretroviral therapy and 15 HIV health workers in Kenya, Malawi and Mozambique to explore patients' and health workers' perspectives on these transitions. Interviews were audio-recorded, transcribed and translated into English. Data were coded inductively and analysed thematically. In all settings, experiences of treatment failure and associated episodes of ill-health disrupted daily social and economic activities, and recalled earlier fears of dying from HIV. Transitioning onto more effective regimens often represented a second (or third) chance to (re-)engage with HIV care, with patients prioritising their health over other aspects of their lives. However, many patients struggled to maintain these transformations, particularly when faced with persistent social challenges to pill-taking, alongside the burden of more complex regimens and an inability to mobilise sufficient resources to accommodate change. Efforts to identify treatment failure and support regimen change must account for these patients' unique illness and treatment histories, and interventions should incorporate tailored counselling and social and economic support.
越来越多的撒哈拉以南非洲地区的艾滋病毒感染者(PLHIV)正在经历一线抗逆转录病毒治疗失败,并转为二线治疗方案。然而,关于他们的治疗经验的研究却很少。我们在肯尼亚、马拉维和莫桑比克对 43 名接受二线或三线抗逆转录病毒治疗的 PLHIV 和 15 名艾滋病毒卫生工作者进行了深入访谈,以探讨患者和卫生工作者对这些转变的看法。访谈进行了录音、转录并翻译成英文。数据进行了归纳编码,并进行了主题分析。在所有环境中,治疗失败的经历和相关的健康问题都扰乱了日常的社会和经济活动,并让人回想起早些时候因 HIV 而死亡的恐惧。转而使用更有效的治疗方案通常代表着(重新)参与 HIV 护理的第二次(或第三次)机会,患者将健康置于生活的其他方面之上。然而,许多患者难以维持这些转变,尤其是当他们面临持续的服药社会挑战时,加上更复杂的治疗方案的负担,以及无法调动足够的资源来适应变化。识别治疗失败并支持方案改变的努力必须考虑到这些患者独特的疾病和治疗史,干预措施应包括量身定制的咨询以及社会和经济支持。